Growth Metrics

Evolent Health (EVH) Cash & Current Investments (2016 - 2026)

Evolent Health has reported Cash & Current Investments over the past 11 years, most recently at $178.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 8.86% year-over-year to $178.0 million; the TTM value through Dec 2025 reached $178.0 million, up 8.86%, while the annual FY2025 figure was $178.0 million, 8.86% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $178.0 million at Evolent Health, up from $140.4 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $342.0 million in Q4 2021 and troughed at $112.9 million in Q3 2024.
  • A 5-year average of $209.1 million and a median of $204.6 million in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: surged 136.59% in 2021 and later crashed 45.64% in 2024.
  • Year by year, Cash & Current Investments stood at $342.0 million in 2021, then crashed by 40.73% to $202.7 million in 2022, then increased by 1.92% to $206.6 million in 2023, then dropped by 20.86% to $163.5 million in 2024, then grew by 8.86% to $178.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for EVH at $178.0 million in Q4 2025, $140.4 million in Q3 2025, and $175.4 million in Q2 2025.